Patients with active cancer, pregnancy, or specific vascular conditions may not be candidates
FOXO4-DRI: Senolytic Peptide Mechanism and the p53-FOXO4 Axis FOXO4-DRI is a D-retro-inverso peptide that selectively kills senescent cells by disrupting the protective FOXO4-p53 interaction
Drug interactions reviewed individually Drug interactions with other peptides and medications are reviewed before any protocol begins, particularly when stacking with growth peptides
Speed up recovery and protect your joints with QRP Nutrition BPC-157 DS 500mcg, a high-quality peptide supplement designed to support tissue repair, healing, and mobility
Presented for research literature review only Nahata MC et al
At this anchor dose, the per-injection payload is: 1.75 mg GHK-Cu 0.35 mg BPC-157 0.35 mg TB-4 10-unit draw: 2.85 mL BAC water produces 3.5 mg BPC-157/mL